Natural Product: NPC3218

Natural Product IDNPC3218
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Euroabienol
IUPAC Name methyl (1R,4S,4aS,9S,10S,10aR)-4,10-diacetyloxy-5,9-dihydroxy-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate
Synonyms Euroabienol
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL1223332
PubChem CID 46933232
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey FEMTVABTBAWCEK-YTBAPPOLSA-N
Standard InCHI InChI=1S/C25H34O8/c1-12(2)15-10-16-19(17(28)11-15)25(6)18(32-13(3)26)8-9-24(5,23(30)31-7)22(25)21(20(16)29)33-14(4)27/h10-12,18,20-22,28-29H,8-9H2,1-7H3/t18-,20-,21+,22-,24+,25+/m0/s1
SMILES COC(=O)[C@]1(C)CC[C@@H]([C@]2([C@H]1[C@H](OC(=O)C)[C@@H](O)c1c2c(O)cc(c1)C(C)C)C)OC(=O)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   462.23 Volume:   469.79
?
Van der Waals volume.
Dense:   0.984 LogP:   2.727
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.575
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.648
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   7.0 Rigid Bonds:   19.0
TPSA:   119.36
?
Topological Polar Surface Area.
H-Bond Acceptor:   8.0
H-Bond Donor:   2.0 Rings:   3.0
Heavy Atoms:   8.0

MedChem Properties

QED Drug-Likeness Score:   0.517 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.606 Fsp3:   0.64
MCE-18:   91.537
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.634 Fluc inhibitor:   0.003
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.064
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.025
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.089 Promiscuous compounds:   0.223

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.14 MDCK Permeability:   -4.891
Pgp-inhibitor:   0.769 Pgp-substrate:   0.175
PAMPA:   0.555
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.016
20% Bioavailability (F20%):   0.794 30% Bioavailability (F30%):   0.982
50% Bioavailability (F50%):   0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.003 MRP1:   0.999
Plasma Protein Binding (PPB):   83.787% Volume Distribution (VD):   -0.275
Fu: 16.973%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.999
OATP1B3 inhibitor:   0.999 BCRP inhibitor:   0.176
BSEP inhibitor:   0.916

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.325
CYP2C19-inhibitor:   0.006 CYP2C19-substrate:   0.416
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.002
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.002
CYP3A4-inhibitor:   0.812 CYP3A4-substrate:   0.967
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.97
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  8.371 Half-life (T1/2):  0.835

ADMET: Toxicity

hERG Blockers:  0.029 hERG Blockers (10um):  0.439
Human Hepatotoxicity (H-HT):  0.605 Drug-induced Liver Injury (DILI):  0.767
AMES Toxicity:  0.288 Rat Oral Acute Toxicity:  0.578
Maximum Recommended Daily Dose:  0.616 Skin Sensitization:  0.933
Carcinogencity:  0.351 Eye Corrosion:  0.021
Eye Irritation:  0.591 Respiratory Toxicity:  0.626
Drug-induced Neurotoxicity:  0.138 Ototoxicity:  0.471
Hematotoxicity:  0.568 Drug-induced Nephrotoxicity:  0.56
Genotoxicity:  0.392 RPMI-8226 Immunitoxicity:  0.063
A549 Cytotoxicity:  0.625 Hek293 Cytotoxicity:  0.227
BCF:   0.621
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.506
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.048
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.459
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO12357 Lycopus europaeus Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[20674349]
NPO12357 Lycopus europaeus Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO12357 Lycopus europaeus Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO12357 Lycopus europaeus Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO12357 Lycopus europaeus Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1190 Organism Salmonella enterica Salmonella enterica MIC = 179.0 ug.mL-1 PMID[20405847]
NPT5743 Organism Arcanobacterium pyogenes Arcanobacterium pyogenes MIC = 179.0 ug.mL-1 PMID[1479376]
NPT729 Organism Micrococcus luteus Micrococcus luteus MIC = 45.0 ug.mL-1 PMID[15921404]
NPT2242 Organism Penicillium chrysogenum Penicillium chrysogenum MIC = 1433.0 ug.mL-1 PMID[22705001]
NPT1190 Organism Salmonella enterica Salmonella enterica MBC = 1.433 mg/ml PMID[12828469]
NPT5743 Organism Arcanobacterium pyogenes Arcanobacterium pyogenes MBC = 1.433 mg/ml PMID[26225905]
NPT729 Organism Micrococcus luteus Micrococcus luteus MBC = 0.179 mg/ml PMID[26225905]
NPT2242 Organism Penicillium chrysogenum Penicillium chrysogenum MFC = 2.867 mg/ml PMID[26191359]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae MIC = 179.0 ug.mL-1 PMID[2691635]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae MIC = 45.0 ug.mL-1 PMID[2691635]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 179.0 ug.mL-1 PMID[20405847]
NPT20 Organism Candida albicans Candida albicans MIC = 358.0 ug.mL-1 PMID[15921404]
NPT312 Organism Saccharomyces cerevisiae Saccharomyces cerevisiae MIC = 89.0 ug.mL-1 PMID[15921404]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. MIC = 1433.0 ug.mL-1 PMID[20674349]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. MIC > 5735.0 ug.mL-1 PMID[20674349]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae MBC = 1.433 mg/ml DrugMatrix in vivo data: Pathology
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae MBC = 0.716 mg/ml DrugMatrix in vivo data: Pathology
NPT79 Organism Bacillus subtilis Bacillus subtilis MBC = 2.867 mg/ml DrugMatrix in vivo data: Pathology
NPT20 Organism Candida albicans Candida albicans MFC = 1.433 mg/ml PMID[26151487]
NPT312 Organism Saccharomyces cerevisiae Saccharomyces cerevisiae MFC = 0.089 mg/ml PMID[26225905]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. MFC = 2.867 mg/ml PMID[20674349]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. MFC > 5.735 mg/ml PMID[20674349]
NPT19 Organism Escherichia coli Escherichia coli MIC = 358.0 ug.mL-1 PMID[16378364]
NPT19 Organism Escherichia coli Escherichia coli MIC = 716.0 ug.mL-1 PMID[2691635]
NPT19 Organism Escherichia coli Escherichia coli MIC = 179.0 ug.mL-1 PMID[26287401]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC = 358.0 ug.mL-1 PMID[20405847]
NPT766 Organism Proteus vulgaris Proteus vulgaris MIC = 179.0 ug.mL-1 PMID[2691635]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 179.0 ug.mL-1 PMID[15921404]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 22.0 ug.mL-1 PMID[15921404]
NPT87 Organism Aspergillus fumigatus Aspergillus fumigatus MIC = 89.0 ug.mL-1 PMID[22705001]
NPT19 Organism Escherichia coli Escherichia coli MBC = 0.716 mg/ml DrugMatrix in vivo data: Pathology
NPT19 Organism Escherichia coli Escherichia coli MBC = 5.735 mg/ml DrugMatrix in vivo data: Pathology
NPT19 Organism Escherichia coli Escherichia coli MBC = 2.867 mg/ml DrugMatrix in vivo data: Pathology
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MBC = 2.867 mg/ml DrugMatrix in vivo data: Pathology
NPT766 Organism Proteus vulgaris Proteus vulgaris MBC = 5.735 mg/ml DrugMatrix in vivo data: Pathology
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MBC = 5.735 mg/ml PMID[26225905]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MBC = 2.867 mg/ml PMID[26225905]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MBC = 0.716 mg/ml PMID[26225905]
NPT87 Organism Aspergillus fumigatus Aspergillus fumigatus MFC = 0.358 mg/ml PMID[26151487]
NPT314 Organism Bacillus cereus Bacillus cereus MIC = 89.0 ug.mL-1 PMID[1479376]
NPT314 Organism Bacillus cereus Bacillus cereus MBC = 0.716 mg/ml DrugMatrix in vivo data: Pathology

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC3218 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
NPC

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC3218 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data